• 10 WEST 2.42

Accepting Doctoral Students


Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

Tom Freeman is the Director of the Addiction and Mental Health Group (AIM) within the Department of Psychology at the University of Bath. He is a member of Council for the British Association for Psychopharmacology and was supported by the Society for the Study of Addiction as a Senior Academic Fellow. He has given expert evidence to the National Institute of Health and Care Excellence (NICE) on cannabis-based medicines and has completed commissioned projects for the EU on the European cannabis market. He is an Associate Editor for the journal Addiction and holds honorary appointments at the National Addiction Centre at King’s College London and the Clinical Psychopharmacology Unit at UCL.

Tom uses interdisciplinary research methods to investigate the aetiology and treatment of addiction and mental health disorders. These include observational studies to characterise changes in drug products and their relationship to health, experimental medicine studies to understand neurocognitive and biological mechanisms, and clinical trials to evaluate novel interventions. His current interests include changes in cannabis products in international markets, the role of cannabinoids as causes and cures for addiction and mental health disorders, and identfying vulnerability and resilience factors to inform treatment, prevention and harm reduction.

Fingerprint Dive into the research topics where Tom Freeman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Acute and chronic effects of Δ9-tetrahydrocannabinol (THC) on cerebral blood flow: A systematic review

Ogunbiyi, M. O., Hindocha, C., Freeman, T. P. & Bloomfield, M. A. P., 13 Jul 2020, In : Progress in Neuro-Psychopharmacology and Biological Psychiatry. 101, 109900.

Research output: Contribution to journalReview article

1 Citation (Scopus)

Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzyme

Hindocha, C., Freeman, T. P., Schafer, G., Gardner, C., Bloomfield, M. A. P., Bramon, E., Morgan, C. J. A. & Curran, H. V., 31 May 2020, In : Addiction Biology. 25, 3, e12762.

Research output: Contribution to journalArticle

Open Access
4 Citations (Scopus)
1 Downloads (Pure)

Acute effects of cannabis on speech illusions and psychotic-like symptoms: two studies testing the moderating effects of cannabidiol and adolescence

Mokrysz, C., Shaban, N. D. C., Freeman, T. P., Lawn, W., Pope, R. A., Hindocha, C., Freeman, A., Wall, M. B., Bloomfield, M. A. P., Morgan, C. J. A., Nutt, D. J. & Curran, H. V., 28 Apr 2020, In : Psychological Medicine. p. 1-9 9 p.

Research output: Contribution to journalArticle

Open Access
70 Downloads (Pure)

Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials

Chesney, E., Oliver, D., Green, A., Sovi, S., Wilson, J., Englund, A., Freeman, T. P. & McGuire, P., 8 Apr 2020, In : Neuropsychopharmacology.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls

Sami, M., Quattrone, D., Ferraro, L., Tripoli, G., Cascia, E. L., Gayer-Anderson, C., Selten, J-P., Arango, C., Bernardo, M., Tarricone, I., Tortelli, A., Gatto, G., Del Peschio, S., Del-Ben, C. M., Rutten, B. P., Jones, P. B., van Os, J., de Haan, L., Morgan, C., Lewis, C. & 5 others, Bhattacharyya, S., Freeman, T. P., Lynskey, M., Murray, R. M. & Forti, M. D., 28 Apr 2020, In : Psychological Medicine. p. 1-9 9 p.

Research output: Contribution to journalArticle

Open Access
1 Citation (Scopus)
3 Downloads (Pure)